SBM.H — Sirona Biochem Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual income statement for Sirona Biochem, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.136 | 0.106 | 0.268 | 0.672 | 0.035 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 4.6 | 4.27 | 2.58 | 4.2 | 2.44 |
| Operating Profit | -4.46 | -4.17 | -2.32 | -3.53 | -2.41 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -4.56 | -4.14 | -2.31 | -3.55 | -2.54 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.55 | -4.13 | -2.31 | -3.56 | -2.54 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.55 | -4.13 | -2.31 | -3.56 | -2.54 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.55 | -4.13 | -2.31 | -3.56 | -2.54 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.023 | -0.018 | -0.01 | -0.015 | -0.01 |